Tom Dodd

Antigenic variation of Borrelia hermsii.

Herbert G. Stoenner, Tom Dodd, C. Larsen · The Journal of Experimental Medicine · 1982 · 320 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +6

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Serous carcinoma of the uterus—determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation

Pritanjali Singh, Chad Smith, Glenice Cheetham et al. · International Journal of Gynecological Cancer · 2008 · 51 citations

Medicine, Oncology, Pathology +17

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Eun Young Kang, Dane Cheasley, Cécile Le Page et al. · Modern Pathology · 2020 · 41 citations · Full text

Medicine, Gynecology, Oncology +17

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

Bo Gao, Amanda J. Russell, Jonathan Beesley et al. · Scientific Reports · 2014 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17